(Q43812953)

27 November 2017

Sulfonylureas are not associated with increased mortality in diabetics treated with thrombolysis for acute myocardial infarction (English)

1 reference

27 November 2017

1 reference

myocardial infarction

1 reference

A Halkin

1

1 reference

27 November 2017

A Roth

series ordinal

2

1 reference

27 November 2017

M Jonas

series ordinal

3

1 reference

27 November 2017

S Behar

series ordinal

4

1 reference

27 November 2017

1 October 2001

1 reference

Journal of Thrombosis and Thrombolysis

27 November 2017

1 reference

27 November 2017

12

1 reference

27 November 2017

2

1 reference

27 November 2017

177-184

1 reference

https://scigraph.springernature.com/pub.10.1023/a:1012979622945

27 November 2017

0 references

cites work

The optimal mode of coronary revascularization for diabetics. A risk-adjusted long-term study comparing coronary angioplasty and coronary bypass surgery

1 reference

12 December 2020

Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Inf

1 reference

12 December 2020

Oral sulfonylurea hypoglycemic agents prevent ischemic preconditioning in human myocardium. Two paradoxes revisited

1 reference

12 December 2020

Ischemic preconditioning during coronary angioplasty is prevented by glibenclamide, a selective ATP-sensitive K+ channel blocker.

1 reference

12 December 2020

Myocardial infarction in diabetic vs non-diabetic subjects. Survival and infarct size following therapy with sulfonylureas (glibenclamide)

1 reference

12 December 2020

Sulfonylureas and mortality in diabetic patients after myocardial infarction

1 reference

12 December 2020

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

1 reference

12 December 2020

Increased fibrinolytic potential induced by gliclazide in type I and type II diabetic patients

1 reference

12 December 2020

Effect of diabetes mellitus on short- and long-term mortality rates of patients with acute myocardial infarction: a statewide study. Myocardial Infarction Data Acquisition System Study Group

1 reference

12 December 2020

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

1 reference

12 December 2020

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

12 December 2020

The sulfonylurea controversy: more questions from the heart

1 reference

12 December 2020

Arrhythmias and mortality after myocardial infarction in diabetic patients. Relationship to diabetes treatment

1 reference

12 December 2020

A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. II. Mortality results

1 reference

12 December 2020

Plasminogen activator inhibitor-1 in nonobese subjects with non-insulin-dependent diabetes mellitus.

1 reference

12 December 2020

Glibenclamide prevents coronary vasodilation induced by beta 1-adrenoceptor stimulation in dogs

1 reference

12 December 2020

Hemobiological properties of gliclazide

1 reference

12 December 2020

Effect of insulin versus sulfonylurea therapy on cardiovascular risk factors and fibrinolysis in type II diabetes.

1 reference

12 December 2020

Diabetes and coronary artery disease: time to stop taking the tablets?

1 reference

12 December 2020

Exogenous insulin administration and cardiovascular risk in non-insulin-dependent and insulin-dependent diabetes mellitus

1 reference

12 December 2020

Sulfonylurea receptors and mechanism of sulfonylurea action

1 reference

12 December 2020

Environmental and genetic factors in relation to elevated circulating levels of plasminogen activator inhibitor-1 in Caucasian patients with non-insulin-dependent diabetes mellitus.

1 reference

12 December 2020

Emerging concepts in the management of acute myocardial infarction in patients with diabetes mellitus

1 reference

12 December 2020

Outcome of coronary bypass surgery versus coronary angioplasty in diabetic patients with multivessel coronary artery disease

1 reference

12 December 2020

Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.

1 reference

12 December 2020

Sulfonylurea drugs increase early mortality in patients with diabetes mellitus after direct angioplasty for acute myocardial infarction.

1 reference

12 December 2020

Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1012979622945

1 reference

Dimensions Publication ID

27 November 2017

0 references

1 reference